dr. M.B.M. (Majorie) van Duursen
m.vanduursen@uu.nl
Gegenereerd op 2017-11-20 08:56:06


Profile
Majorie is associate professor and toxicologist dedicated to improve the health of (future) mothers and children through science and education. She strives to understand and reduce the risk of environmental contaminants to children’s health globally. To accomplish this mission, she investigates the effects of potential toxicants on female health and the developing child, thereby avoiding unnecessary harm for animals. Majorie translates these findings into practice and policy and disseminate to (inter)national scientific, societal and political communities in order to encourage healthy living from an early age. As principle investigator, she has been involved in and coordinated various projects on the toxicological impact of environmental contaminants. Majorie represents Health and Environment Alliance (HEAL) in the Endocrine Disruption Expert Group from ECHA. She lectures in general toxicological principles and endocrine toxicology at the Faculties of Veterinary Medicine, Biomedical Sciences and Life Sciences of the Utrecht University. 
Scientific expertise
Gegenereerd op 2017-11-20 08:56:06
Curriculum vitae Download PDF
Gegenereerd op 2017-11-20 08:56:06
All publications
  Articles - 2017
van Duursen, Majorie B.M., van Ede, Karin I. & van den Berg, Martin (2017). One TEF concept does not fit all: The case for human risk assessment of polychlorinated biphenyls. Current Opinion in Toxicology , 2, (pp. 103-108) (6 p.).
  Articles - 2016
van Ede, Karin I, van Duursen, Majorie B M & van den Berg, Martin (2016). Evaluation of relative effect potencies (REPs) for dioxin-like compounds to derive systemic or human-specific TEFs to improve human risk assessment. Archiv fur Toxikologie, 90 (6), (pp. 1293-1305) (13 p.).
Wimmerová, Soňa, van den Berg, Martin, Chovancová, Jana, Patayová, Henrieta, Jusko, Todd A, van Duursen, Majorie B M, Palkovičová Murínová, Ľubica, Canton, Rocio F, van Ede, Karin I & Trnovec, Tomáš (30.08.2016). Relative effect potency estimates of dioxin-like activity for dioxins, furans, and dioxin-like PCBs in adults based on cytochrome P450 1A1 and 1B1 gene expression in blood. Environmental International, 96, (pp. 24-33) (10 p.). Copyright © 2016. Published by Elsevier Ltd..
  Articles - 2015
Larsson, Malin, van den Berg, Martin, Brenerová, Petra, van Duursen, Majorie B M, van Ede, Karin I, Lohr, Christiane, Luecke-Johansson, Sandra, Machala, Miroslav, Neser, Sylke, Pěnčíková, Kateřina, Poellinger, Lorenz, Schrenk, Dieter, Strapáčová, Simona, Vondráček, Jan & Andersson, Patrik L (20.04.2015). Consensus Toxicity Factors for Polychlorinated Dibenzo-p-dioxins, Dibenzofurans, and Biphenyls Combining in Silico Models and Extensive in Vitro Screening of AhR-Mediated Effects in Human and Rodent Cells. Chemical Research in Toxicology, 28 (4), (pp. 641-650) (10 p.).
van Ede, Karin, Gaisch, Konrad, van den Berg, Martin & van Duursen, Majorie (22.01.2015). Reply to Koppe and Ten Tusscher's letter to the Editor concerning the use of human peripheral blood lymphocytes to determine relative effect potencies for dioxin like compounds. Toxicology Letters, 232 (2), (pp. 544-545) (2 p.).
Roelofs, Maarke J, van den Berg, Martin, Bovee, Toine F H, Piersma, Aldert H & van Duursen, Majorie B (08.01.2015). Structural bisphenol analogues differentially target steroidogenesis in murine MA-10 Leydig cells as well as the glucocorticoid receptor. Toxicology, 329C, (pp. 10-20) (11 p.). Copyright © 2015 Elsevier Ireland Ltd. All rights reserved..
  Articles - 2014
Chottanapund, Suthat, Van Duursen, M. B M, Navasumrit, Panida, Hunsonti, Potchanee, Timtavorn, Supatchaya, Ruchirawat, Mathuros & Van den Berg, Martin (01.01.2014). Anti-aromatase effect of resveratrol and melatonin on hormonal positive breast cancer cells co-cultured with breast adipose fibroblasts. Toxicology in Vitro, 28 (7), (pp. 1215-1221) (7 p.).
Van Ede, Karin I., Andersson, Patrik L., Gaisch, Konrad P J, Van Den Berg, Martin & Van Duursen, Majorie B M (01.03.2014). Comparison of intake and systemic relative effect potencies of dioxin-like compounds in female rats after a single oral dose. Archiv fur Toxikologie, 88 (3), (pp. 637-646) (10 p.).
Roelofs, Maarke J.E., Temming, A. Roberto, Piersma, Aldert H., van den Berg, Martin & van Duursen, Majorie B.M. (2014). Conazole fungicides inhibit Leydig cell testosterone secretion and androgen receptor activation in vitro. Toxicology Reports, 1, (pp. 271-283) (13 p.).
Van Ede, Karin I., Gaisch, Konrad P J, Van den Berg, Martin & Van Duursen, Majorie B M (07.04.2014). Differential relative effect potencies of some dioxin-like compounds in human peripheral blood lymphocytes and murine splenic cells. Toxicology Letters, 226 (1), (pp. 43-52) (10 p.).
Solak, Kamila A., Wijnolts, Fiona M.J., Nijmeijer, Sandra M., Blaauboer, Bas J., van den Berg, Martin & van Duursen, Majorie B.M. (2014). Excessive levels of diverse phytoestrogens can modulate steroidogenesis and cell migration of KGN human granulosa-derived tumor cells. Toxicology Reports, 1, (pp. 360-372) (13 p.).
Ghorbanzadeh, Mehdi, Van Ede, Karin I., Larsson, Malin, Van Duursen, Majorie B M, Poellinger, Lorenz, Lücke-Johansson, Sandra, Machala, Miroslav, Pěnčíková, Kateřina, Vondráček, Jan, Van Den Berg, Martin, Denison, Michael S., Ringsted, Tine & Andersson, Patrik L. (21.07.2014). In vitro and in silico derived relative effect potencies of ah-receptor-mediated effects by PCDD/Fs and PCBs in rat, mouse, and guinea pig CALUX cell lines. Chemical Research in Toxicology, 27 (7), (pp. 1120-1132) (13 p.).
Solak, Kamila A., Santos, Regiane R., van den Berg, Martin, Blaauboer, Bas J., Roelen, Bernard A J & van Duursen, Majorie B M (2014). Naringenin (NAR) and 8-prenylnaringenin (8-PN) reduce the developmental competence of porcine oocytes in vitro. Reproductive Toxicology, 49, (pp. 1-11) (11 p.).
  Articles - 2013
Schulz, V.J., van Roest, M., Bol-Schoenmakers, M., van Duursen, M.B.M., van den Berg, M., Pieters, R.H.H. & Smit, J.J. (2013). Aryl hydrocarbon receptor activation affects the dendritic cell phenotype and function during allergic sensitization. Immunobiology, 218 (8), (pp. 1055-1062) (8 p.).
Chapin, R.E., Boekelheide, K., Cortvrindt, R., van Duursen, M.B.M., Gant, T., Jegou, B., Marczylo, E., van Pelt, A.M.M., Post, J.N., Roelofs, M.J.E., Schlatt, S., Teerds, K.J., Toppari, J. & Piersma, A.H. (2013). Assuring safety without animal testing: the case for the human testis in vitro. Reproductive Toxicology, 39, (pp. 63-68) (6 p.).
van Ede, K.I., Andersson, P.L., Gaisch, K.P., van den Berg, M. & van Duursen, M.B.M. (2013). Comparison of intake and systemic relative effect potencies of dioxin-like compounds in female mice after a single oral dose. Environmental Health Perspectives, 121 (7), (pp. 847-853) (7 p.).
Chottanapund, S., van Duursen, M.B.M., Navasumrit, P., Hunsonti, P., Timtavorn, S., Ruchirawat, M. & van den Berg, M. (2013). Effect of androgens on different breast cancer cells co-cultured with or without breast adipose fibroblasts. Journal of Steroid Biochemistry and Molecular Biology, 138C, (pp. 54-62) (9 p.).
Dankers, Anita C A, Roelofs, Maarke J E, Piersma, Aldert H, Sweep, Fred C G J, Russel, Frans G M, van den Berg, Martin, van Duursen, Majorie B M & Masereeuw, R. (2013). Endocrine disruptors differentially target ATP-binding cassette transporters in the blood-testis barrier and affect Leydig cell testosterone secretion in vitro. Toxicological Sciences, 136 (2), (pp. 382-391) (10 p.).
Piersma, A.H., Bosgra, S., van Duursen, M.B.M., Hermsen, S.A.B., Jonker, L.R., Kroese, E.D., Linden, S.C., Man, H., Roelofs, M.J.E., Schulpen, S.H., Schwarz, M., Uibel, F., van Vugt-Lussenburg, B.M., Westerhout, J., Wolterbeek, A.P.M. & van der Burg, B. (2013). Evaluation of an alternative in vitro test battery for detecting reproductive toxicants. Reproductive Toxicology, 38, (pp. 53-64) (12 p.).
van Duursen, M.B.M. (06.09.2013). Fyto eostrogenen niet goed bij borstkanker. NRC
Solak, K.A., Wijnolts, F.M.J., Pralong, F.P., Blaauboer, B.J., van den Berg, M., Westerink, R.H.S. & van Duursen, M.B.M. (2013). In vitro neuroendocrine effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the AhR-expressing hypothalamic rat GnV-3 cell line. Toxicology, 311 (3), (pp. 124-134) (11 p.).
van Duursen, M.B.M., Smeets, E.E., Rijk, J.C., Nijmeijer, S.M. & van den Berg, M. (2013). Phytoestrogens in menopausal supplements induce ER-dependent cell proliferation and overcome breast cancer treatment in an in vitro breast cancer model. Toxicology and Applied Pharmacology, 269 (2), (pp. 132-140) (9 p.).
van Duursen, M.B.M., van den Broek, I.V., de Jong, P.C. & van den Berg, M. (2013). Risico’s van fyto-oestrogenen uit voedingssupplementen bij adjuvante hormonale therapie voor borstkanker. Nederlands Tijdschrift voor Geneeskunde, 157 (39), (pp. A6069) (1 p.).
Roelofs, M.J.E., Piersma, A.H., van den Berg, M. & van Duursen, M.B.M. (2013). The relevance of chemical interactions with CYP17 enzyme activity: assessment using a novel in vitro assay. Toxicology and Applied Pharmacology, 268 (3), (pp. 309-317) (9 p.).
van Ede, K.I., Aylward, L.L., Andersson, P.L., van den Berg, M. & van Duursen, M.B.M. (2013). Tissue distribution of dioxin-like compounds: potential impacts on systemic relative potency estimates. Toxicology Letters, 220 (3), (pp. 294-302) (9 p.).
  Articles - 2012
Antolino-Lobo, I., Meulenbelt, J., van den Berg, M. & van Duursen, M.B.M. (2012). A mechanistic insight into 3,4-methylenedioxymethamphetamine ("ecstasy")-mediated hepatotoxicity. Veterinary Quarterly, 31 (4), (pp. 193-205) (13 p.).
Schulz, V.J., Smit, J.J., Bol-Schoenmakers, M., van Duursen, M.B.M., van den Berg, M. & Pieters, R.H.H. (2012). Activation of the aryl hydrocarbon receptor reduces the number of precursor and effector T cells, but preserves thymic CD4(+)CD25(+)Foxp3(+) regulatory T cells. Toxicology Letters, 215 (2), (pp. 100-109) (10 p.).
Schulz, V.J., Smit, J.J., Huijgen, V.C., Bol-Schoenmakers, M., van Roest, M., Kruijssen, L.W.J., Fiechter, D., Hassing, I., Bleumink, A.R.J., Safe, S., van Duursen, M.B.M., van den Berg, M. & Pieters, R.H.H. (2012). Non-dioxin-like AhR ligands in a mouse peanut allergy model. Toxicological Sciences, 128 (1), (pp. 92-102) (11 p.).
  Articles - 2011
Antolino-Lobo, I., Meulenbelt, J., Nijmeijer, S.M., Maas-Bakker, R.F.M., Meijerman, I., van den Berg, M. & van Duursen, M.B.M. (2011). 3,4-methylenedioxymethamphetamine (MDMA) interacts with therapeutic drugs on CYP3A by inhibition of pregnane X receptor (PXR) activation and catalytic enzyme inhibition. Toxicology Letters, 203 (1), (pp. 82-91) (10 p.).
Schulz, V.J., Smit, J.J., Willemsen, K.J., Fiechter, D., Hassing, I., Bleumink, R., Boon, L, van den Berg, M., van Duursen, M.B.M. & Pieters, R.H.H. (2011). Activation of the aryl hydrocarbon receptor suppresses sensitization in a mouse peanut allergy model. Toxicological Sciences, 123 (2), (pp. 491-500) (10 p.).
van Duursen, M.B.M., Nijmeijer, S.M., de Morree, E.S., de Jong, P.C. & van den Berg, M. (2011). Genistein induces breast cancer-associated aromatase and stimulates estrogen-dependent tumor cell growth in in vitro breast cancer model. Toxicology, 289 (2-3), (pp. 67-73) (7 p.).
Antolino-Lobo, I., Meulenbelt, J., Molendijk, J., Nijmeijer, S.M., Scherpenisse, P., van den Berg, M. & van Duursen, M.B.M. (2011). Induction of glutathione synthesis and conjugation by 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-dihydroxymethamphetamine (HHMA) in human and rat liver cells, including the protective role of some antioxidants. Toxicology, 289 (2-3), (pp. 175-184) (10 p.).
Stenberg, M., Hamers, T., Machala, M., Fonnum, F., Stenius, U., Lauy, A., van Duursen, M.B.M. & Westerink, R.H.S. (2011). Multivariate toxicity profiles and QSAR modeling of non-dioxin-like PCBs - An investigation of in vitro screening data from ultra-pure congeners. Chemosphere, 85 (9), (pp. 1423-1429) (7 p.).
Antunes Fernandes, E.C., Bovee, T.F., Daamen, F.E., Helsdingen, R.J., van den Berg, M. & van Duursen, M.B.M. (2011). Some OH-PCBs are more potent inhibitors of aromatase activity and (anti-) glucocorticoids than non-dioxin like (NDL)-PCBs and MeSO₂-PCBs. Toxicology Letters, 206 (2), (pp. 158-165) (8 p.).
Vrabie, C.M., Candido, A., van den Berg, H., Murk, A.J., van Duursen, M.B.M. & Jonker, M.T.O. (2011). Specific in vitro toxicity of crude and refined petroleum products: 3. Estrogenic responses in mammalian assays. Environmental Toxicology and Chemistry, 30 (4), (pp. 973-980) (8 p.).
  Articles - 2010
van Duursen, M.B.M., Nijmeijer, S.M., Ruchirawat, S. & van den Berg, M. (2010). Chemopreventive actions by enterolactone and 13 VIOXX-related lactone derivatives in H295R human adrenocortical carcinoma cells. Toxicology Letters, 192 (3), (pp. 271-277) (7 p.).
Antolino Lobo, I., Meulenbelt, J., Nijmeijer, S.M., Scherpenisse, P., van den Berg, M. & van Duursen, M.B.M. (2010). Differential roles of phase I and phase II enzymes in 3,4-methylendioxymethamphetamine-induced cytotoxicity. Drug Metabolism and Disposition, 38 (7), (pp. 1105-1112) (8 p.).
Vrabie, C.M., Candido, A., van Duursen, M.B.M. & Jonker, M.T.O. (2010). Specific in vitro toxicity of crude and refined petroleum products: II. Estrogen (alpha and beta) and androgen receptor-mediated responses in yeast assays. Environmental Toxicology and Chemistry, 29 (7), (pp. 1529-1536) (7 p.).
  Articles - 2009
Sangjun, S., de Jong, E., Nijmeijer, S., Mutarapat, T., Ruchirawat, S., van den Berg, M. & van Duursen, M.B.M. (2009). Induction of cell cycle arrest in human MCF-7 breast cancer cells by cis-stilbene derivatives related to VIOXX. Toxicology Letters, 186 (2), (pp. 115-122) (8 p.).
Bovee, T.F., Bor, G., Becue, I., Daamen, F.E., van Duursen, M.B.M., Lehmann, S., Vollmer, G., De Maria, R., Fox, J.W., Witters, H., Bernhoft, S., Schramm, K.W., Hoogenboom, R.L. & Nielen, M.W. (2009). Inter-laboratory comparison of a yeast bioassay for the determination of estrogenic activity in biological samples. Analytica Chimica Acta, 637 (1-2), (pp. 265-272) (8 p.).
  Articles - 2007
Bovee, T.F., Helsdingen, R.J.R., Hamers, A.R., van Duursen, M.B.M., Nielen, M.W. & Hoogenboom, R.L. (2007). A new highly specific and robust yeast androgen bioassay for the detection of agonists and antagonists. Fresenius Zeitschrift fur Analytische Chemie, 389 (5), (pp. 1549-1558) (10 p.).
  Articles - 2005
van Duursen, M.B.M., Sanderson, J.T. & van den Berg, M. (2005). Cytochrome P450 1A1 and 1B1 in human blood lymphocytes are not suitable as biomarkers of exposure to dioxin-like compounds: Polymorphisms and interindividual variation in expression and inducibility. Toxicological Sciences, 85, (pp. 703-712) (10 p.).
van Duursen, M.B.M., Fernández Cantón, R., Kočan, T., Sanderson, J.T., Kieviet, K. & van den Berg, M. (2005). No effect of CYP1B1 val432leu polymorphism on CYP1B1 messenger RNA levels in an organochlorine-exposed population in Slovakia. Cancer Epidemiology Biomarkers and Prevention, 14 (3), (pp. 755-756) (2 p.).
  Articles - 2004
van Duursen, M.B.M., Sanderson, J.T., de Jong, P.C., Kraaij, M. & van den Berg, M. (2004). Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage. Toxicological Sciences, 81, (pp. 316-324) (9 p.).
  Articles - 2003
van Duursen, M.B.M., Sanderson, J.T., van Bruggen, M., van der Linden, J. & van den Berg, M. (2003). Effects of dioxin-like compounds on estrogen metabolism in MCF-7 and MCF-10A cell lines. Organohalogen Compounds, 65, (pp. 284-287) (4 p.).
van Duursen, M.B.M., Sanderson, J.T., van der Bruggen, M., van der Linden, J. & van den Berg, M. (2003). Effects of several dioxin-like compounds on estrogen metabolism in the malignant MCF-7 and nontumorigenic MCF-10A human mammary epithelial cell lines. Toxicology and Applied Pharmacology, 190 (3), (pp. 241-250) (10 p.).
  Lectures - 2016
M.B.M. van Duursen (24.10.2016) Developmental Origin of Health and Disease (DOHaD): the Role of Early Life Exposures. Chem-Academy. Vienna (AU), 24-25 October 2016. Invited speaker
M.B.M. van Duursen (15.01.2016) Hormoonverstorende stoffen: een goede start voor een gezond leven. Netherlands Institute for Biology (NIBI) Conference Hormonale en neurale regeling. Lunteren (NL). 15 January 2016
M.B.M. van Duursen (04.09.2016) In vitro female health hazard assessment of natural compounds in dietary supplements. EUROTOX 2016. Sevilla, 4-7 September 2016. Invited speaker, Session organizer
M.B.M. van Duursen (16.02.2016) Normstelling PerfluorAlkyl Stoffen (PFAS) vanuit een toxicologisch perspectief. Symposium Expertisecentrum PFOS/PFAS. Deventer (NL). 16 February 2016
M.B.M. van Duursen (28.01.2016) Toxicity testing in the 21st century: challenges and 3R opportunities. HAN BioCentre 10th Anniversary Symposium. Nijmegen (NL), 28 January 2016
M.B.M. van Duursen (26.10.2016) Workshop leader. WORKSHOP ENDOCRINE DISRUPTORS: ALTERNATIVE AND NEW METHODS IN ENDOCRINE TOXICITY TESTING Chem-Academy. Vienna (AU), 26 Oct 2016
  Lectures - 2015
M.B.M. van Duursen (10.11.2015) EDCs: translating science to improve public health. Fresenius Conference on EDCs. 10-11 November 2015, Cologne, Germany. Keynote lecture.
M.B.M. van Duursen (07.01.2015) Endocrine Disrupting Chemicals and cancer. Members of the European Parliament (MEPs) Against Cancer briefing. Regulation on endocrine disrupting chemicals; an opportunity to stop cancer before it starts. 7 January 2015, Brussels, Belgium
  Lectures - 2013
M.B.M. van Duursen (26.08.2013) Development and Analysis of QSAR Models in the EU-SysTEQ project for use as aid in assessing risks of PCBs, PCDDs AND PCDFs
M.B.M. van Duursen (26.08.2013) EU-SYSTEQ: AhR-Mediated Toxicity of PCB126 is over-estimated
M.B.M. van Duursen (26.08.2013) Intake and systemic relative effect potencies of Dioxin-like compounds in female mice and rats after a single oraldose within the EU-project SYSTEQ
M.B.M. van Duursen (26.08.2013) The use of TEF factors in Risk Assessment; Limitations, pitfalls and the role of the EU-SYSTEQ project
  Lectures - 2012
M.B.M. van Duursen (10.07.2012) Adjuvant endocrine therapy in human and canine breast cancer treatment
  Lectures - 2010
M.B.M. van Duursen (16.09.2010) CYP1A1 induction in lymphocytes from mice and humans: a biomarker of dioxin exposure?
M.B.M. van Duursen (17.11.2010) Endocrine toxicology and hormone-dependent cancer - the use of veterinary tissues as in vitro models.
  Lectures - 0
M.B.M. van Duursen () https://www.theparliamentmagazine.eu/articles/opinion/europe-wide-cancer-group-calls-action-hormone-disruptors Europe-wide cancer group calls for action on hormone disruptors Written by Christel Schaldemose on 9 January 2015 in Opinion Christel Schaldemose is calling on the EU to take urgent action in the fight against cancer by identifying and eliminating endocrine disrupting chemicals (EDCs). A representative of one of Europe's most influential cancer organisations, the association of European cancer leagues (ECL) recently told a meeting of MEPs against cancer that curbing exposure to endocrine disrupting chemicals should become a central part of cancer prevention strategy in Europe. ECL, which focuses on the prevention and control of cancer, brings together national and regional cancer leagues with a staff of more than 6000 throughout Europe. Its director Wendy Tse Yared said that rapid rises in rates of breast and prostate cancer in recent decades could not be explained by improved diagnostics. She noted that this upward trend coincided with an increase in chemicals and that sufficient evidence now exists that endocrine disrupting chemicals heighten cancer risk. Effective regulation could contribute to reductions in hormonal cancers, including of the breast, which is the most commonly diagnosed cancer in women and of the prostate, the most commonly diagnosed cancer in men. It may also help to bring down rates of testicular cancer, which is increasing among young men in Europe. A recent study by Nordic countries on male reproductive health problems associated with these chemicals suggested that endocrine disrupting chemicals might be responsible for up to 40 per cent of all cases of testicular cancer. "What is needed now is a proper identification of EDCs – one that ensures these harmful chemicals are found and ultimately eliminated" Dutch toxicologist Dr Majorie B.M. van Duursen told the meeting that numerous studies on breast cancer showed that exposure to endocrine disrupting chemicals, such as BPA, PBDE and pesticides, can adversely affect the normal development of the mammary gland, potentially making it more susceptible to cancers. She stressed that one or two new studies were appearing each day on endocrine disrupting chemicals and chronic conditions, including hormonal cancers, infertility, obesity and diabetes. A review by the world health organisation in 2012 recorded the considerable advances in the scientific evidence that had been made since 2002. No-one can say that we don't know enough to justify reducing people's exposure to these chemicals, said Dr Duursen. The not-for-profit Health and Environment Alliance (HEAL), which brings together over 70 member organisations to address how environmental protection can improve health in the European Union has been advocating stronger action to reduce exposure to harmful chemicals for many years. Genon K. Jensen, HEAL's director told the meeting that her members, which include cancer groups, are convinced that exposure to EDCs is a likely explanation of why cancers that are hormone dependent have been rising. She said that HEAL was part of a coalition of non-governmental organisations called 'EDC-Free Europe' that was helping ordinary individuals to respond to the EU consultation on EDCs. An online platform launched five weeks ago has allowed more than 10,000 individuals to respond. But despite the rapidly growing scientific evidence and the growing public concern, the delays in effective action continue. What is needed now is a proper identification of EDCs – one that ensures these harmful chemicals are found and ultimately eliminated. My hope is that this MEPs against cancer meeting will help convince the commission that action now needs to happen. Not tomorrow, but today. About the author Christel Schaldemose is vice-president of MEPs against cancer
M.B.M. van Duursen () International Jubilee Scientific Meeting of the Netherlands Society of Toxicology ‘Tox21 : Intelligent Toxicity Testing’
M.B.M. van Duursen () International Jubilee Scientific Meeting of the Netherlands Society of Toxicology ‘Tox21 : Intelligent Toxicity Testing’
M.B.M. van Duursen () Persbijeenkomst Nieuwspoort: Hormoonverstorende Stoffen.
  Television or radio appearances - 0
M.B.M. van Duursen () Vervrouwelijking-van-het-water
  Contribution to the work of national or international committees and working groups - 0
M.B.M. van Duursen () Advisory Council Women in Europe for a Common Future (WECF) – A safe start for children
M.B.M. van Duursen () Associate Faculty member of Faculty of 1000
M.B.M. van Duursen () Board Member
M.B.M. van Duursen () Board Member
M.B.M. van Duursen () Board Member
M.B.M. van Duursen () Endocrine Disruptor Expert Group van ECHA (European Chemical Agency), on request of HEAL (Health Environment Alliance)
M.B.M. van Duursen () Lid Commissie van Toezicht
M.B.M. van Duursen () Luncheon briefing: An opportunity to prevent non-communicable diseases via change in environmental policy.
M.B.M. van Duursen () Member Netherlands Federation for Innovative Drug Research (FIGON).
M.B.M. van Duursen () Member of the American Society of Toxicology (SOT).
M.B.M. van Duursen () Member of the Supervising Committee of the Post-doctoral Education in Toxicology
M.B.M. van Duursen () Member Organising Committee Anniversary Meeting
M.B.M. van Duursen () Member WHO Collaborating Centre for Environmental Health Risk Assessment – Children’s Environmental Health initiative
M.B.M. van Duursen () Regulation on endocrine disrupting chemicals; an opportunity to stop cancer before it starts.
  Membership of external research organisation - 0
M.B.M. van Duursen () - Associate Faculty member of Faculty of 1000
M.B.M. van Duursen () member - WHO Collaborative Centers on Children’s Environmental Health
M.B.M. van Duursen () Member of the Concilium Toxicologicum
  Research and Teaching at External Organisation - 2015
M.B.M. van Duursen (14.12.2015) -Training/education on Endocrine disrupting chemicals (EDCs) for midwives at Wilhelmina Kinder Ziekenhuis (UMCU), Utrecht
  Research and Teaching at External Organisation - 0
M.B.M. van Duursen () Member - NVT Opleidingscommissie
M.B.M. van Duursen () member - PET (postgraduate education in toxicology) commissie van Toezicht
  Doctoral thesis 1 (Research UU / Graduation UU) - 2005
van Duursen, M.B.M. (27.01.2005). Estrogen metabolizing enzymes biomarkers of exposure, effect and susceptibility for carcinogenesis. (144 p.).
^ top
Gegenereerd op 2017-11-20 08:56:07
Additional functions and activities

Independent expert/Stakeholder representative for Health and Environment Alliance (HEAL) at the Endocrine Disruptor Expert Group of the European Chemical Agency (ECHA)

Gegenereerd op 2017-11-20 08:56:07
Full name
dr. M.B.M. van Duursen Contact details
Nieuw Gildestein

Yalelaan 2
Room 1032
3584 CM  UTRECHT
The Netherlands


Jeannette Donker-Voetgebouw

Yalelaan 104-106
Room 1.032
3584 CM  UTRECHT
The Netherlands


Phone number (direct) +31 30 253 5398
Postal address
Postbus 80.177
3508 TD    UTRECHT
The Netherlands
Availability
Mo Tue Wed Thu Fr
Morning
Afternoon
Gegenereerd op 2017-11-20 08:56:07
Last updated 13.06.2017